Jeffrey S Farrow Insider Trading
Get free email notifications about insider trading for Jeffrey S Farrow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey S Farrow. Jeffrey S Farrow is a V.P., Finance and CAO in RENOVIS INC ($RNVS) and a CFO in HYPERION THERAPEUTICS INC ($HPTX) and a Chief Financial Officer in ZS Pharma, Inc. ($ZSPH) and a Chief Financial Officer in Global Blood Therapeutics, Inc. ($GBT).
Address: TWO CORPORATE DRIVE SOUTH SAN FRANCISCO 94080 CA
Companies in which Jeffrey S Farrow is an Insider
Global Blood Therapeutics, Inc.
Trading Symbol: GBTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S Farrow: Chief Financial Officer
Holdings: 21,267 shares
Current Value: $344,525
Latest Transaction: Feb 03 2021
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HYPERION THERAPEUTICS INC
Trading Symbol: HPTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S Farrow: CFO
Holdings: 0 shares
Latest Transaction: May 08 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RENOVIS INC
Trading Symbol: RNVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S Farrow: V.P., Finance and CAO
Holdings: 0 shares
Latest Transaction: May 06 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZS Pharma, Inc.
Trading Symbol: ZSPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S Farrow: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Dec 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey S Farrow
Sentiment: All, GBT, HPTX, RNVS, ZSPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,020 | 0 | 18,120 | |
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 12,500 | |
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 5,750 | |
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,063 | 0 | 0 | |
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 49.49 | 5,865 | 290,259 | 15,402 | 21.3 K to 15.4 K (-27.58 %) |
Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 12,083 | 0 | 21,267 | 9.2 K to 21.3 K (+131.57 %) |
Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,020 | 0 | 21,140 |